Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Iodine-123 MIBG imaging in a generalized pancreatic polypeptide-gastrin-serotonin secreting tumor

Journal Article · · Clin. Nucl. Med.; (United States)
The usefulness of radio-metaiodobenzylguanidine (MIBG), a specific radiopharmaceutical agent for scintigraphic imaging and treatment of phaeochromocytoma and neuroblastoma, has been extended to the location of carcinoid tumors. Scintigraphic evaluation with I-123 MIBG in a patient with a histologically proven endocrine tumor (apudoma) of unknown origin with liver and bone metastases is reported. Elevated plasma hormone levels of gastrin, pancreatic polypeptide, and serotonin were found. Tumoral content of these hormones was immunocytochemically confirmed on liver biopsy. I-123 MIBG uptake could be seen in those areas of the liver with deficient lesions in the Tc-99m colloid image with a maximal uptake in a large mass at the level of the left liver lobe. No abnormal uptake could be observed at any other level, which was in contrast with autopsy findings of generalized metastatic disease.
Research Organization:
Vrije Universiteit Brussels (Belgium)
OSTI ID:
7001410
Journal Information:
Clin. Nucl. Med.; (United States), Journal Name: Clin. Nucl. Med.; (United States) Vol. 13:5; ISSN CNMED
Country of Publication:
United States
Language:
English

Similar Records

Scintigraphic imaging of carcinoid tumors
Conference · Wed May 01 00:00:00 EDT 1985 · J. Nucl. Med.; (United States) · OSTI ID:6644510

Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine
Journal Article · Mon Nov 30 23:00:00 EST 1987 · J. Nucl. Med.; (United States) · OSTI ID:5606110

Radiochemistry, biochemistry, and kinetics of /sup 131/I-metaiodobenzylguanidine (MIBG) and /sup 123/I-MIBG: clinical implications of the use of /sup 123/I-MIBG
Journal Article · Wed Dec 31 23:00:00 EST 1986 · Med. Pediatr. Oncol.; (United States) · OSTI ID:5841269